中國銀行(601988.SH):擬出資130億澳門元投設澳門子行 作為所屬一級全資子公司管理
格隆匯8月23日丨中國銀行(601988.SH)公佈,該行擬出資130億澳門元投資設立中國銀行(澳門)股份有限公司(“澳門子行”),作為該行所屬一級全資子公司管理。
該行已收到中國銀行保險監督管理委員會的批覆和中國澳門特別行政區政府的許可,同意該行設立澳門子行。
此次投資是該行為服務國家戰略、支持粵港澳大灣區建設、滿足中國澳門特別行政區政府發展特色金融需要的重要舉措。澳門子行將與現有澳門分行形成合力,構建面向澳門政府、國內外大型企業、當地居民及中小企業的全方位服務體系,提供涵蓋商業銀行、資產管理、保險、基金、投資和信託等多領域的服務產品,做大做強該行在澳門地區的業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.